Anfield Capital Management, LLC Heron Therapeutics, Inc. Transaction History
Anfield Capital Management, LLC
- $258 Million
- Q1 2025
A detailed history of Anfield Capital Management, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Anfield Capital Management, LLC holds 141,185 shares of HRTX stock, worth $268,251. This represents 0.12% of its overall portfolio holdings.
Number of Shares
141,185
Previous 118,976
18.67%
Holding current value
$268,251
Previous $182,000
70.33%
% of portfolio
0.12%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding HRTX
# of Institutions
182Shares Held
125MCall Options Held
847KPut Options Held
47.7K-
Rubric Capital Management LP New York, NY26.7MShares$50.8 Million1.68% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$15.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.23MShares$15.6 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.85MShares$14.9 Million0.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$13.3 Million26.51% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $226M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...